Back to Centiva Capital, LP Centiva Capital, LP

MREOMREO
Showing 8 of 17 quarters

Position history for Centiva Capital, LPCentiva Capital, LP's holdings in MEREO BIOPHARMA GROUP PLC

Centiva Capital, LP holds 25,000 shares of MREO (MEREO BIOPHARMA GROUP PLC), worth $7,943 as of 2026-Q2. MREO represents 0.0% of Centiva Capital, LP's portfolio.

Current Value

$7,943

Current Shares

25,000

Total Value Change

-$94,807

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
25,000
0.0%
$7,9430.0%$0.32
0
2026-Q1
Unchanged
25,000
0.0%
$8,2500.0%$0.41
0
2025-Q4
Unchanged
25,000
0.0%
$10,4180.0%$0.37
0
2025-Q3
Unchanged
25,000
0.0%
$51,5000.0%$1.96
0
2025-Q2
Unchanged
25,000
0.0%
$67,7500.0%$2.66
0
2025-Q1
Unchanged
25,000
0.0%
$56,2500.0%$2.30
0
2024-Q4
Unchanged
25,000
0.0%
$87,5000.0%$3.52
0
2024-Q3
Unchanged
25,000
0.0%
$102,7500.0%$4.14
0

Other major holders of MREO: Janus Henderson Group Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used